サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1403348

心血管デバイスの世界市場予測（～2030年）：デバイスタイプ、用途、エンドユーザー、地域別の分析

Cardiovascular Devices Market Forecasts to 2030 - Global Analysis By Device Type, Application (Coronary Artery Disease, Heart Failure, Cardiac Arrhythmia and Other Applications), End User and By Geography
出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
心血管デバイスの世界市場予測（～2030年）：デバイスタイプ、用途、エンドユーザー、地域別の分析
出版日: 2024年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の心血管デバイスの市場規模は、2023年に656億6,000万米ドルを占め、2030年には1,271億5,000万米ドルに達すると予測され、予測期間中のCAGRは9.9％です。

循環器系機器は、疾患や循環器系の診断、治療、モニタリングを目的とした医療機器です。不整脈、冠動脈疾患、心不全など、さまざまな心血管疾患を治療することで、医療において重要な役割を果たしています。ペースメーカー、除細動器、画像診断装置、モニタリングシステム、カテーテルなどがその一例です。これらの機器の重要性は、効果的な治療法を提供し、正確な診断を容易にし、患者の転帰を改善する能力に由来します。

世界保健機関（WHO）によると、心血管疾患に関連する死亡の約75％は中低所得国で発生しています。

心血管疾患の有病率の上昇

心不全、不整脈、冠動脈疾患（CADD）などの心血管疾患（CVD）の有病率の上昇は、座りがちなライフスタイル、不健康な食生活、タバコの使用、高齢化など、いくつかの要因に起因しています。このような疾病負担の増大により、革新的な心血管デバイスや技術の需要が高まっています。埋め込み型除細動器（ICD）、ペースメーカー、薬剤溶出ステント、心臓モニタリング・デバイスなどのデバイスは、さまざまな心血管系疾患の診断、治療、管理において極めて重要な役割を果たしています。これらの先端技術は、患者の予後を改善し、死亡率を低下させ、罹患者の全体的な生活の質を高めるのに役立っています。そのため、市場拡大への需要が高まっています。

研究開発活動における障壁の増加

規制当局のモニタリングが厳しくなり、安全基準も厳しくなり、大規模な臨床試験が必要になるため、研究開発コストと期間が大幅に上昇します。こうした障壁は中小企業や新興企業に不釣り合いな影響を及ぼし、市場参入や技術革新の能力を制限しています。既存企業もまた、研究開発に多額の投資を必要とする障害に直面しています。このような研究開発のハードルの高さが、新しい心血管デバイスのタイムリーな導入を妨げ、技術革新と市場成長を妨げています。

遠隔医療と遠隔モニタリング

遠隔医療と遠隔モニタリングは、バイタルサイン、心拍リズム、その他の関連データをリアルタイムで遠隔モニタリングできるようにすることで、患者の継続的なケアを促進します。心血管系患者にとっては、在宅モニタリングの利便性、病院受診の減少、医療へのアクセスの向上がもたらされます。先進的なウェアラブルデバイス、モバイルアプリ、コネクテッドプラットフォームにより、医療専門家は遠隔で患者の状態を評価し、タイムリーな介入を行い、個人に合ったケアを提供することができ、最終的には患者の転帰を改善することができます。循環器における遠隔医療と遠隔モニタリングの統合はまた、革新の道を開き、遠隔モニタリングと遠隔医療用途向けに調整された、より洗練された、ユーザーフレンドリーで効果的な循環器デバイスの開発を促進します。

厳しい規制

進化する厳しい規制要件は、承認プロセスの長期化、コンプライアンスコストの増大、新規機器導入の障壁の増大を招く可能性があります。これらの規制は、特に複雑な規制状況を乗り切るためのリソースが限られている中小企業にとっては、技術革新や市場参入を阻害する可能性があります。また、規制の変更や不確実性は、既存の市場戦略や投資を混乱させ、製品開発のタイムラインや市場競争力に影響を与える可能性があります。

COVID-19の影響

COVID-19の流行は、さまざまな形で心血管デバイス市場に大きな影響を与えました。当初は、パンデミックの管理に重点が移され、医療資源の再配分や緊急治療以外の治療を受けたがらない患者により、心血管疾患に対する選択的手術や診断の減少を招きました。サプライチェーンの混乱や製造上の制約も、機器の可用性に影響を与えました。しかし、パンデミックは遠隔医療と遠隔モニタリングソリューションの採用を加速させ、心血管治療のためのデジタルヘルスの技術革新を促進しました。ワクチン接種率が上昇し、医療システムが新常態に適応するにつれて、選択的手術は徐々に回復しました。

診断・モニタリング機器セグメントは予測期間中最大になる見込み

診断・モニタリング機器セグメントは、心血管の状態を検出、モニタリング、評価するために設計された高度な技術により、最大のシェアを占めると推定されます。これらの機器は、心臓リズム、血圧、その他のバイタルサインのリアルタイムモニタリングを可能にし、異常の早期発見を助け、継続的な患者ケアを促進します。さらに、これらの機器は様々な心血管系疾患の診断において極めて重要な役割を果たし、医療専門家に正確な評価、個人に合わせた治療戦略、患者の転帰改善のための重要なデータを提供し、最終的には心臓疾患のより良い管理とケアに貢献します。

予測期間中、冠動脈疾患（CAD）セグメントのCAGRが最も高くなると予測されます。

冠動脈疾患（CAD）セグメントは予測期間中に有利な成長が見込まれます。冠動脈疾患（CAD）とは、心臓に酸素を豊富に含む血液を供給する冠動脈の狭窄や閉塞のことです。これらの機器は、心臓への血流を回復させ、症状を緩和し、心臓発作のリスクを低減するのに役立ちます。CAD専用機器は、経皮的冠動脈インターベンション（PCI）や冠動脈バイパス移植術（CABG）などのインターベンションを支援し、この一般的な心血管疾患の管理と患者の心臓の健康と生活の質の向上に極めて重要な役割を果たしています。

最大のシェアを占める地域

推定期間中、アジア太平洋地域が最大の市場シェアを占めています。アジア太平洋地域は、中国、インド、日本などの国々で、心臓に関連する疾患の治療に焦点を当てた医療技術の多様な景観を包含しています。この急成長市場は、心臓リズム管理デバイス、ステント、診断ツールなどの進歩を特徴としています。さらに、心血管疾患の増加、医療インフラの改善、革新的な医療ソリューションの採用増加などの要因が市場の拡大に寄与しています。技術革新と医療意識の高まりの融合により、アジア太平洋地域は心血管デバイス需要の急増を目の当たりにしています。

CAGRが最も高い地域：

北米は、米国とカナダを主要な貢献国としており、その強固で成熟した状況により、予測期間中に有益な成長を遂げることが期待されます。高度な医療技術で知られるこの市場には、ペースメーカー、除細動器、ステント、イメージングツールなど、さまざまな心血管デバイスがあります。さらに、高額な医療支出、洗練された医療インフラ、大規模な患者プールなどの要因が市場成長を後押ししています。低侵襲手術の革新は、研究開発の重視と相まって、最先端の心血管技術におけるこの地域のリーダーシップに貢献し、患者の予後改善に焦点を当てた競合市場環境を醸成しています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

  • 企業プロファイル
    • 追加市場プレイヤーの包括的プロファイリング（3社まで）
    • 主要企業のSWOT分析（3社まで）
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 用途分析
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の心血管デバイス市場：デバイスタイプ別

  • 診断・モニタリングデバイス
    • 遠隔心臓モニタリング
    • 心電図（ECG）
  • 治療・外科用機器
    • 心臓補助装置
    • カテーテル
    • 心拍リズム管理デバイス
    • 移植片
    • ステント
    • 心臓弁
  • 他のデバイスタイプ

第6章 世界の心血管デバイス市場：用途別

  • 冠動脈疾患（CAD）
  • 心不全
  • 心不整脈
  • その他の用途

第7章 世界の心血管デバイス市場：エンドユーザー別

  • 専門クリニック
  • 病院
  • 心臓センター
  • 外来外科センター

第8章 世界の心血管デバイス市場：地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第9章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第10章 企業プロファイル

  • Abbott
  • Cardinal Health
  • Boston Scientific Corporation
  • General Electric（GE Healthcare）
  • Medtronic
  • W. L. Gore & Associates, Inc.
  • Biotronik
  • Canon Medical Systems Corporation
  • Siemens Healthcare Gmbh
  • Edwards Lifesciences Corporation
  • Livanova PLC
  • B. Braun Melsungen AG
  • Johnson & Johnson Services, Inc.
  • Terumo Cardiovascular Systems Corporation
  • Philips Healthcare
  • Microport Scientific Corporation
  • Lepu Medical Technology（Beijing）Co Ltd
  • Occlutech
  • Getinge AB
  • Atricure, Inc
目次
Product Code: SMRC24573

According to Stratistics MRC, the Global Cardiovascular Devices Market is accounted for $65.66 billion in 2023 and is expected to reach $127.15 billion by 2030 growing at a CAGR of 9.9% during the forecast period. Cardiology devices are medical equipment intended to diagnose, treat, and monitor diseases and cardiovascular systems. They play a vital role in healthcare by treating a range of cardiovascular disorders, including arrhythmias, coronary artery disease, and heart failure. Some of these devices are pacemakers, defibrillators, imaging equipment, monitoring systems, and catheters. Their importance derives from their capacity to provide effective treatment initiatives, facilitate precise diagnosis, and improve patient outcomes-all of which significantly raise standards for cardiac health and save lives.

According to the World Health Organization, around 75% of the cardiovascular diseases related deaths occur in low and middle income countries.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular diseases

The rising prevalence of cardiovascular diseases (CVDs) such heart failure, arrhythmias, and coronary artery disease (CADD) is attributed to several factors, including sedentary lifestyles, unhealthy diets, tobacco use, and ageing populations. This escalating disease burden necessitates a greater demand for innovative cardiovascular devices and technologies. Devices such as implantable cardioverter-defibrillators (ICDs), pacemakers, drug-eluting stents, and cardiac monitoring devices play pivotal roles in diagnosing, treating, and managing various cardiovascular conditions. These advanced technologies aid in improving patient outcomes, reducing mortality rates, and enhancing the overall quality of life for affected individuals. Therefore, there is an increasing demand for market expansion.

Restraint:

Increasing barriers in R&D activities

Heightened regulatory scrutiny, demanding safety standards, and the necessity for extensive clinical trials significantly elevate R&D costs and timelines. These barriers disproportionately affect smaller companies and start-ups, limiting their ability to enter the market and innovate. Established players also encounter impediments, requiring substantial investments in R&D. These mounting hurdles in R&D hinder the timely introduction of novel cardiovascular devices, impeding innovation and market growth.

Opportunity:

Telemedicine and remote monitoring

Telemedicine and remote monitoring facilitate continuous patient care by enabling remote monitoring of vital signs, cardiac rhythms, and other relevant data in real-time. For cardiovascular patients, this offers the convenience of home-based monitoring, reducing hospital visits, and enhancing accessibility to healthcare. Advanced wearable devices, mobile apps, and connected platforms allow healthcare professionals to remotely assess patients' conditions, provide timely interventions, and offer personalised care, ultimately improving patient outcomes. The integration of telemedicine and remote monitoring in cardiovascular also opens avenues for innovation, driving the development of more sophisticated, user-friendly, and effective cardiovascular devices tailored for remote monitoring and telehealth applications.

Threat:

Stringent regulations

Evolving and stringent regulatory requirements can result in prolonged approval processes, increased compliance costs, and heightened barriers for new device introductions. These regulations may inhibit innovation and market entry, particularly for smaller companies with limited resources to navigate complex regulatory landscapes. Also, regulatory changes or uncertainties might disrupt existing market strategies and investments, impacting product development timelines and market competitiveness.

COVID-19 Impact

The COVID-19 pandemic significantly affected the cardiovascular device market in various ways. Initially, the focus shifted towards managing the pandemic, causing a decline in elective procedures and diagnostics for cardiovascular conditions due to healthcare resource reallocation and patient reluctance to seek non-emergency care. Supply chain disruptions and manufacturing constraints also impacted device availability. However, the pandemic accelerated the adoption of telemedicine and remote monitoring solutions, driving innovation in digital health for cardiovascular care. As vaccination rates increased and healthcare systems adapted to the new normal, there was a gradual rebound in elective procedures.

The Diagnostic and Monitoring Devices segment is expected to be the largest during the forecast period

The Diagnostic and Monitoring Devices segment is estimated to hold the largest share, due to the advanced technologies designed to detect, monitor, and assess cardiovascular conditions. They enable real-time monitoring of heart rhythms, blood pressure, and other vital signs, aiding in the early detection of abnormalities and facilitating continuous patient care. Additionally, these devices play a pivotal role in diagnosing various cardiovascular diseases, providing healthcare professionals with crucial data for accurate assessments, personalised treatment strategies, and improved patient outcomes, ultimately contributing to better management and care of cardiac

The Coronary Artery Disease (CAD) segment is expected to have the highest CAGR during the forecast period

The Coronary Artery Disease (CAD) segment is anticipated to have lucrative growth during the forecast period. Coronary artery disease (CAD) is a narrowing or blockage of your coronary arteries, which supply oxygen-rich blood to the heart. These devices help restore blood flow to the heart, alleviate symptoms, and reduce the risk of heart attacks. CAD-specific devices aid in interventions such as percutaneous coronary interventions (PCI) and coronary artery bypass grafting (CABG), playing a pivotal role in managing this prevalent cardiovascular condition and improving patients' cardiac health and quality of life.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period. It encompasses a diverse landscape of medical technologies focused on treating heart-related conditions across countries like China, India, Japan, and others. This rapidly growing market features advancements in cardiac rhythm management devices, stents, diagnostic tools, and more. Moreover, factors such as rising cardiovascular diseases, improving healthcare infrastructure, and increasing adoption of innovative medical solutions contribute to the market's expansion. With a blend of technological innovation and growing healthcare awareness, the Asia Pacific region is witnessing a surge in demand for cardiovascular devices.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to its robust and mature landscape, encompassing the United States and Canada as key contributors. Known for its advanced medical technologies, this market hosts a wide array of cardiovascular devices, including pacemakers, defibrillators, stents, and imaging tools. Furthermore, factors such as high healthcare spending, sophisticated healthcare infrastructure, and a large patient pool drive market growth. Innovations in minimally invasive procedures, coupled with a strong emphasis on research and development, contribute to the region's leadership in cutting-edge cardiovascular technologies, fostering a competitive market environment with a focus on improving patient outcomes

Key players in the market:

Some of the key players in the Cardiovascular Devices Market include Abbott, Cardinal Health, Boston Scientific Corporation, General Electric (GE Healthcare), Medtronic, W. L. Gore & Associates, Inc., Biotronik, Canon Medical Systems Corporation, Siemens Healthcare GmbH., Edwards Lifesciences Corporation, LivaNova PLC, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., Terumo Cardiovascular Systems Corporation, Philips Healthcare, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co Ltd, Occlutech, Getinge AB and AtriCure, Inc.

Key Developments:

In October 2022, Medtronic plc received United States FDA approval for expanded labeling of a cardiac lead that taps into the heart's natural electrical system, giving patients needed therapy while avoiding complications sometimes associated with traditional pacing methods, such as cardiomyopathy.

In October 2022, Biosense Webster, Inc., part of Johnson & Johnson MedTech launched the HELIOSTAR Balloon Ablation Catheter in Europe. The HELIOSTAR Balloon Ablation Catheter is indicated for use in the catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria and, when used with a compatible multi-channel RF generator, for cardiac ablation.

Device Types Covered:

  • Diagnostic and Monitoring Devices
  • Therapeutic and Surgical Devices
  • Other Device Types

Applications Covered:

  • Coronary Artery Disease (CAD)
  • Heart Failure
  • Cardiac Arrhythmia
  • Other Applications

End Users Covered:

  • Specialty Clinics
  • Hospitals
  • Cardiac Centers
  • Centers Ambulatory Surgical

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cardiovascular Devices Market, By Device Type

  • 5.1 Introduction
  • 5.2 Diagnostic and Monitoring Devices
    • 5.2.1 Remote Cardiac Monitoring
    • 5.2.2 Electrocardiogram (ECG)
  • 5.3 Therapeutic and Surgical Devices
    • 5.3.1 Cardiac Assist Devices
    • 5.3.2 Catheters
    • 5.3.3 Cardiac Rhythm Management Devices
    • 5.3.4 Grafts
    • 5.3.5 Stents
    • 5.3.6 Heart Valves
  • 5.4 Other Device Types

6 Global Cardiovascular Devices Market, By Application

  • 6.1 Introduction
  • 6.2 Coronary Artery Disease (CAD)
  • 6.3 Heart Failure
  • 6.4 Cardiac Arrhythmia
  • 6.5 Other Applications

7 Global Cardiovascular Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Specialty Clinics
  • 7.3 Hospitals
  • 7.4 Cardiac Centers
  • 7.5 Centers Ambulatory Surgical

8 Global Cardiovascular Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest Of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest Of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest Of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest Of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations And Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott
  • 10.2 Cardinal Health
  • 10.3 Boston Scientific Corporation
  • 10.4 General Electric (GE Healthcare)
  • 10.5 Medtronic
  • 10.6 W. L. Gore & Associates, Inc.
  • 10.7 Biotronik
  • 10.8 Canon Medical Systems Corporation
  • 10.9 Siemens Healthcare Gmbh
  • 10.10 Edwards Lifesciences Corporation
  • 10.11 Livanova PLC
  • 10.12 B. Braun Melsungen AG
  • 10.13 Johnson & Johnson Services, Inc.
  • 10.14 Terumo Cardiovascular Systems Corporation
  • 10.15 Philips Healthcare
  • 10.16 Microport Scientific Corporation
  • 10.17 Lepu Medical Technology(Beijing)Co Ltd
  • 10.18 Occlutech
  • 10.19 Getinge AB
  • 10.20 Atricure, Inc

List Of Tables

  • Table 1 Global Cardiovascular Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 3 Global Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 4 Global Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 5 Global Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 6 Global Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 7 Global Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 8 Global Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 9 Global Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 10 Global Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 11 Global Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 12 Global Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 13 Global Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 14 Global Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 15 Global Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 16 Global Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 17 Global Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 18 Global Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 20 Global Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 21 Global Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 22 Global Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 23 North America Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 25 North America Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 26 North America Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 27 North America Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 28 North America Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 29 North America Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 30 North America Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 31 North America Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 32 North America Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 33 North America Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 34 North America Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 35 North America Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 36 North America Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 37 North America Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 38 North America Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 39 North America Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 40 North America Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 41 North America Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 42 North America Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 43 North America Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 44 North America Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 45 Europe Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 47 Europe Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 48 Europe Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 49 Europe Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 50 Europe Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 51 Europe Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 52 Europe Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 53 Europe Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 54 Europe Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 55 Europe Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 56 Europe Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 57 Europe Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 58 Europe Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 59 Europe Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 60 Europe Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 61 Europe Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 62 Europe Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 63 Europe Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 64 Europe Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 65 Europe Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 66 Europe Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 67 Asia Pacific Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 70 Asia Pacific Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 71 Asia Pacific Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 72 Asia Pacific Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 73 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 74 Asia Pacific Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 75 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 76 Asia Pacific Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 77 Asia Pacific Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 78 Asia Pacific Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 79 Asia Pacific Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 80 Asia Pacific Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 81 Asia Pacific Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 82 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 83 Asia Pacific Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 84 Asia Pacific Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 85 Asia Pacific Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 86 Asia Pacific Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 87 Asia Pacific Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 88 Asia Pacific Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 89 South America Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 91 South America Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 92 South America Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 93 South America Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 94 South America Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 95 South America Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 96 South America Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 97 South America Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 98 South America Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 99 South America Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 100 South America Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 101 South America Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 102 South America Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 103 South America Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 104 South America Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 105 South America Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 106 South America Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 107 South America Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 108 South America Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 109 South America Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 110 South America Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)
  • Table 111 Middle East & Africa Cardiovascular Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Cardiovascular Devices Market Outlook, By Device Type (2021-2030) ($MN)
  • Table 113 Middle East & Africa Cardiovascular Devices Market Outlook, By Diagnostic And Monitoring Devices (2021-2030) ($MN)
  • Table 114 Middle East & Africa Cardiovascular Devices Market Outlook, By Remote Cardiac Monitoring (2021-2030) ($MN)
  • Table 115 Middle East & Africa Cardiovascular Devices Market Outlook, By Electrocardiogram (ECG) (2021-2030) ($MN)
  • Table 116 Middle East & Africa Cardiovascular Devices Market Outlook, By Therapeutic And Surgical Devices (2021-2030) ($MN)
  • Table 117 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Assist Devices (2021-2030) ($MN)
  • Table 118 Middle East & Africa Cardiovascular Devices Market Outlook, By Catheters (2021-2030) ($MN)
  • Table 119 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Rhythm Management Devices (2021-2030) ($MN)
  • Table 120 Middle East & Africa Cardiovascular Devices Market Outlook, By Grafts (2021-2030) ($MN)
  • Table 121 Middle East & Africa Cardiovascular Devices Market Outlook, By Stents (2021-2030) ($MN)
  • Table 122 Middle East & Africa Cardiovascular Devices Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 123 Middle East & Africa Cardiovascular Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 124 Middle East & Africa Cardiovascular Devices Market Outlook, By Coronary Artery Disease (CAD) (2021-2030) ($MN)
  • Table 125 Middle East & Africa Cardiovascular Devices Market Outlook, By Heart Failure (2021-2030) ($MN)
  • Table 126 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Arrhythmia (2021-2030) ($MN)
  • Table 127 Middle East & Africa Cardiovascular Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 128 Middle East & Africa Cardiovascular Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 129 Middle East & Africa Cardiovascular Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 130 Middle East & Africa Cardiovascular Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 131 Middle East & Africa Cardiovascular Devices Market Outlook, By Cardiac Centers (2021-2030) ($MN)
  • Table 132 Middle East & Africa Cardiovascular Devices Market Outlook, By Centers Ambulatory Surgical (2021-2030) ($MN)